Literature DB >> 33297567

Structural and Biochemical Features of Eimeria tenella Dihydroorotate Dehydrogenase, a Potential Drug Target.

Dan Sato1, Endah Dwi Hartuti2, Daniel Ken Inaoka3,4,5, Takaya Sakura3,4, Eri Amalia5, Madoka Nagahama1, Yukina Yoshioka1, Naotoshi Tsuji6, Tomoyoshi Nozaki5, Kiyoshi Kita4,5,7, Shigeharu Harada1, Makoto Matsubayashi8, Tomoo Shiba1.   

Abstract

Dihydroorotate dehydrogenase (DHODH) is a mitochondrial monotopic membrane protein that plays an essential role in the pyrimidine de novo biosynthesis and electron transport chain pathways. In Eimeria tenella, an intracellular apicomplexan parasite that causes the most severe form of chicken coccidiosis, the activity of pyrimidine salvage pathway at the intracellular stage is negligible and it relies on the pyrimidine de novo biosynthesis pathway. Therefore, the enzymes of the de novo pathway are considered potential drug target candidates for the design of compounds with activity against this parasite. Although, DHODHs from E. tenella (EtDHODH), Plasmodium falciparum (PfDHODH), and human (HsDHODH) show distinct sensitivities to classical DHODH inhibitors, in this paper, we identify ferulenol as a potent inhibitor of both EtDHODH and HsDHODH. Additionally, we report the crystal structures of EtDHODH and HsDHODH in the absence and presence of ferulenol. Comparison of these enzymes showed that despite similar overall structures, the EtDHODH has a long insertion in the N-terminal helix region that assumes a disordered configuration. In addition, the crystal structures revealed that the ferulenol binding pocket of EtDHODH is larger than that of HsDHODH. These differences can be explored to accelerate structure-based design of inhibitors specifically targeting EtDHODH.

Entities:  

Keywords:  Eimeria tenella; apicomplexa; coccidium; crystal structure; dihydroorotate dehydrogenase; electron transport chain; inhibitor; membrane protein; mitochondria; ubiquinone

Year:  2020        PMID: 33297567      PMCID: PMC7762340          DOI: 10.3390/genes11121468

Source DB:  PubMed          Journal:  Genes (Basel)        ISSN: 2073-4425            Impact factor:   4.096


  61 in total

1.  Structures of Trypanosoma cruzi dihydroorotate dehydrogenase complexed with substrates and products: atomic resolution insights into mechanisms of dihydroorotate oxidation and fumarate reduction.

Authors:  Daniel Ken Inaoka; Kimitoshi Sakamoto; Hironari Shimizu; Tomoo Shiba; Genji Kurisu; Takeshi Nara; Takashi Aoki; Kiyoshi Kita; Shigeharu Harada
Journal:  Biochemistry       Date:  2008-09-23       Impact factor: 3.162

2.  Purine metabolism in the intact sporozoites and merozoites of Eimeria tenella.

Authors:  S W LaFon; D J Nelson
Journal:  Mol Biochem Parasitol       Date:  1985-01       Impact factor: 1.759

3.  Ferulenol specifically inhibits succinate ubiquinone reductase at the level of the ubiquinone cycle.

Authors:  Mesbah Lahouel; Roland Zini; Ammar Zellagui; Salah Rhouati; Pierre-Alain Carrupt; Didier Morin
Journal:  Biochem Biophys Res Commun       Date:  2007-02-02       Impact factor: 3.575

4.  Toward understanding the role of mitochondrial complex II in the intraerythrocytic stages of Plasmodium falciparum: gene targeting of the Fp subunit.

Authors:  Takeshi Q Tanaka; Makoto Hirai; Yoh-ichi Watanabe; Kiyoshi Kita
Journal:  Parasitol Int       Date:  2012-06-12       Impact factor: 2.230

5.  Jalview Version 2--a multiple sequence alignment editor and analysis workbench.

Authors:  Andrew M Waterhouse; James B Procter; David M A Martin; Michèle Clamp; Geoffrey J Barton
Journal:  Bioinformatics       Date:  2009-01-16       Impact factor: 6.937

6.  DSM265 for Plasmodium falciparum chemoprophylaxis: a randomised, double blinded, phase 1 trial with controlled human malaria infection.

Authors:  Mihály Sulyok; Thomas Rückle; Alexandra Roth; Raymund E Mürbeth; Stephan Chalon; Nicola Kerr; Sonia Schnieper Samec; Nathalie Gobeau; Carlos Lamsfus Calle; Javier Ibáñez; Zita Sulyok; Jana Held; Tamirat Gebru; Patricia Granados; Sina Brückner; Christian Nguetse; Juliana Mengue; Albert Lalremruata; B Kim Lee Sim; Stephen L Hoffman; Jörg J Möhrle; Peter G Kremsner; Benjamin Mordmüller
Journal:  Lancet Infect Dis       Date:  2017-03-28       Impact factor: 25.071

7.  Suppression of experimental cerebral malaria by disruption of malate:quinone oxidoreductase.

Authors:  Mamoru Niikura; Keisuke Komatsuya; Shin-Ichi Inoue; Risa Matsuda; Hiroko Asahi; Daniel Ken Inaoka; Kiyoshi Kita; Fumie Kobayashi
Journal:  Malar J       Date:  2017-06-12       Impact factor: 2.979

8.  Selective Cytotoxicity of Dihydroorotate Dehydrogenase Inhibitors to Human Cancer Cells Under Hypoxia and Nutrient-Deprived Conditions.

Authors:  Yukiko Miyazaki; Daniel K Inaoka; Tomoo Shiba; Hiroyuki Saimoto; Takaya Sakura; Eri Amalia; Yasutoshi Kido; Chika Sakai; Mari Nakamura; Anthony L Moore; Shigeharu Harada; Kiyoshi Kita
Journal:  Front Pharmacol       Date:  2018-09-04       Impact factor: 5.810

9.  Crystal structures of FMN-bound and FMN-free forms of dihydroorotate dehydrogenase from Trypanosoma brucei.

Authors:  Tomomi Kubota; Osamu Tani; Tomohiko Yamaguchi; Ichiji Namatame; Hitoshi Sakashita; Koji Furukawa; Kazuhiko Yamasaki
Journal:  FEBS Open Bio       Date:  2018-03-06       Impact factor: 2.693

10.  DSM265 at 400 Milligrams Clears Asexual Stage Parasites but Not Mature Gametocytes from the Blood of Healthy Subjects Experimentally Infected with Plasmodium falciparum.

Authors:  Katharine A Collins; Thomas Rückle; Suzanne Elliott; Louise Marquart; Emma Ballard; Stephan Chalon; Paul Griffin; Jörg J Möhrle; James S McCarthy
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

View more
  1 in total

1.  Identification of 3,4-Dihydro-2H,6H-pyrimido[1,2-c][1,3]benzothiazin-6-imine Derivatives as Novel Selective Inhibitors of Plasmodium falciparum Dihydroorotate Dehydrogenase.

Authors:  Endah Dwi Hartuti; Takaya Sakura; Mohammed S O Tagod; Eri Yoshida; Xinying Wang; Kota Mochizuki; Rajib Acharjee; Yuichi Matsuo; Fuyuki Tokumasu; Mihoko Mori; Danang Waluyo; Kazuro Shiomi; Tomoyoshi Nozaki; Shinjiro Hamano; Tomoo Shiba; Kiyoshi Kita; Daniel Ken Inaoka
Journal:  Int J Mol Sci       Date:  2021-07-05       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.